Prior to founding Medical Minds, our team developed oncology initiatives for most of the major oncology companies. Starting in the 1990s, our team served as the agency of record at BioGenesis/Torre Lazur McCann for the global launches of Rituxan® and Herceptin®, the first 2 monoclonal antibody therapies for cancer. Since then we have contributed to the success of dozens of oncology products and services covering almost every type of cancer.
Team Experience: Comprehensive Education and Promotion in the Prelaunch/Launch of More Than 30 Oncology Products and Services
| Cancer | Products |
| Breast cancer | Roche/Herceptin®; Novartis/Tykerb®; Novartis/Afinitor®; Athenex/oPAC+E, OBI/GLORIA study |
| Breast cancer diagnostics | Genoptix Medical Laboratory/Aqua®; Monogram Biosciences/ HERmark®; OncoPlexDx |
| Cervical cancer/ precancerous lesions | Nutcracker Therapeutics/NTX-250 mRNA liponanoparticle (phase 1) |
| Colon cancer | AGA/CRC Screening; Cell Pathways/Prevatac™ (phase 3); Genentech/Avastin® MSL Training; Genomic Health/Oncotype DX®; Novartis/Gleevec® |
| CML/ALL/AML/CLL | Novartis/Gleevec®; Novartis/Tasigna®; BeiGene/Brukinsa® |
| High-grade glioma | Tocagen/TOCA 511 & TOCA FC (phase 1/2) |
| Non-Hodgkin lymphoma | Genentech/ Rituxan®; Genitope/MyVax®; BiogenIdec/Zevalin® |
| NSCLC | Boehringer Ingelheim-EmergingMed/NSCLC biomarker education; Lilly/Gemzar® |
| Melanoma | Chiron/Proleukin®; Cancervax/Canvaxin™ (phase 3) Novartis/Tafinar®/Mekinist®; BMS/Yervoy® |
| Myeloma | Millenium/Velcade®; The Binding Site/Freelite®, Hevylite® |
| Oncology franchise | Agouron-Pfizer; CytomX/Probody® Therapeutics; Genentech BioOncology; Schering Intron; Teva HEOR; Novartis ribociclib; InterVenn cancer biomarkers |
| Oncology genomics | Personalis/NeXT Dx Advanced genomic sequencing (breast, CRC, lung, melanoma) |
| Prostate cancer | Schering/Eulexin® |
| Patient advocacy | NCCS/Cancer Survival Toolbox®; George Washington Cancer Institute/A Practical Guide to Life After Cancer |
| Thyroid diagnostics | Genzyme/Thyrogen®; Veracyte/Afirma® |
Patient Advocacy Is Our Passion
Two members of our senior staff are cancer survivors. From personal experience and through working on patient education and advocacy since the late 1990s, few agencies can match our knowledge and capabilities in this important area. For example, in a long-term relationship with the National Coalition for Cancer Survivorship (NCCS) starting in 1997, we have created, developed, produced, and managed the award-winning self-advocacy program known as the Cancer Survival Toolbox® in English and Spanish. Still available and relevant today the Cancer Survival Toolbox® has been accessed by more than a million cancer survivors.
View program / See case study